Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)

mBio(2023)10.1128/mbio.01090-23Source: DataRank Database

Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4) is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.50)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Takuya Tada ORCID,Nathaniel R. Landau ORCID,Ramanjit Kaur ORCID

Live enrichment

PubMed:37382452 PMC:PMC10470548 OpenAlex:https://openalex.org/W4382502122

HHS | National Institutes of Health

Grant: DA046100

HHS | National Institutes of Health

Grant: AI122390, AI120898

NIDA NIH HHS

Grant: DP1 DA046100

National Institutes of Health

Grant: 5K08AI120898-03

Lentiviral Vector Vaccine for HIV-1

National Institutes of Health

Grant: 5R33AI122390-04

Dendritic Cell Vaccine for Controlling the Latent Reservoir

National Institutes of Health

Grant: 1DP1DA046100-01

Therapeutic Dendritic Cell Vaccine for HIV

FWCI

2.50

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.01090-23

publisherhttps://doi.org/10.1128/mbio.01090-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.01090-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37382452

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10470548

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesinterferon and immune responses0301 basic medicine03 medical and health sciencesAnimalsHumansMiceAntiviral AgentsCoronavirus OC43, HumanCOVID-19InterferonsPandemicsRNA, ViralSARS-CoV-2Virus ReplicationMolecular ChaperonesSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2AnimalsAntiviral AgentsHumansInterferonsRNA, ViralVirus ReplicationMolecular ChaperonesCoronavirus OC43, HumanMicePandemics

Keywords

CoronavirusVirologyBiologyViral replicationInterferonVirusGeneGeneticsMedicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)DiseaseInterferonsType-i InterferonHcov-oc43Sars-cov-2Rtp4COVID-19Virus ReplicationMicrobiologyAntiviral AgentsQR1-502Coronavirus OC43, HumanMiceAnimalsHumansRNA, ViralPandemicsResearch ArticleMolecular Chaperones

Sustainable Development Goals

SDG 0: Good health and well-being

Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)